The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to ...

According to wastewater data aggregated by the Centers for Disease Control and Prevention, not only was there less Covid ...

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Former health minister Khairy Jamaluddin said the government was duty-bound to advocate vaccination to the public to mitigate ...

Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.

Cramer noted that the Dow plunged by 337 points, the S&P 500 fell 0.5%, and the Nasdaq declined by 0.28%. Adding fuel to the ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Pfizer's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the fourth quarter.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.